About (2R)-4-[[2-[4-bromo-1-(cyclopropylmethyl)benzotriazol-5-yl]oxy-5-fluoro-3-pyridinyl]methyl]-2-tert-butyl-2-methylpiperazine-1-carboxylic acid
(2R)-4-[[2-[4-bromo-1-(cyclopropylmethyl)benzotriazol-5-yl]oxy-5-fluoro-3-pyridinyl]methyl]-2-tert-butyl-2-methylpiperazine-1-carboxylic acid (PubChem CID 67955411) has the molecular formula C26H32BrFN6O3
and a molecular weight of 575.48 g/mol. Its IUPAC name is (2R)-4-[[2-[4-bromo-1-(cyclopropylmethyl)benzotriazol-5-yl]oxy-5-fluoro-3-pyridinyl]methyl]-2-tert-butyl-2-methylpiperazine-1-carboxylic acid.
Molecular Properties
| Compound Name | (2R)-4-[[2-[4-bromo-1-(cyclopropylmethyl)benzotriazol-5-yl]oxy-5-fluoro-3-pyridinyl]methyl]-2-tert-butyl-2-methylpiperazine-1-carboxylic acid |
| PubChem CID | 67955411 |
| Molecular Formula | C26H32BrFN6O3 |
| Molecular Weight | 575.48 g/mol |
| Exact Mass | 574.17 |
| IUPAC Name | (2R)-4-[[2-[4-bromo-1-(cyclopropylmethyl)benzotriazol-5-yl]oxy-5-fluoro-3-pyridinyl]methyl]-2-tert-butyl-2-methylpiperazine-1-carboxylic acid |
| SMILES | CC(C)(C)[C@]1(C)CN(Cc2cc(F)cnc2Oc2ccc3c(nnn3CC3CC3)c2Br)CCN1C(=O)O |
| InChI | InChI=1S/C26H32BrFN6O3/c1-25(2,3)26(4)15-32(9-10-33(26)24(35)36)14-17-11-18(28)12-29-23(17)37-20-8-7-19-22(21(20)27)30-31-34(19)13-16-5-6-16/h7-8,11-12,16H,5-6,9-10,13-15H2,1-4H3,(H,35,36)/t26-/m0/s1 |
| InChIKey | UAUAEYFWMOYMIW-SANMLTNESA-N |
| XLogP | 5.53 |
| TPSA | 96.61 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 575.48 |
| LogP ≤ 5 | 5.53 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Analyze (2R)-4-[[2-[4-bromo-1-(cyclopropylmethyl)benzotriazol-5-yl]oxy-5-fluoro-3-pyridinyl]methyl]-2-tert-butyl-2-methylpiperazine-1-carboxylic acid with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of (2R)-4-[[2-[4-bromo-1-(cyclopropylmethyl)benzotriazol-5-yl]oxy-5-fluoro-3-pyridinyl]methyl]-2-tert-butyl-2-methylpiperazine-1-carboxylic acid?
The IUPAC name of (2R)-4-[[2-[4-bromo-1-(cyclopropylmethyl)benzotriazol-5-yl]oxy-5-fluoro-3-pyridinyl]methyl]-2-tert-butyl-2-methylpiperazine-1-carboxylic acid (CID 67955411) is (2R)-4-[[2-[4-bromo-1-(cyclopropylmethyl)benzotriazol-5-yl]oxy-5-fluoro-3-pyridinyl]methyl]-2-tert-butyl-2-methylpiperazine-1-carboxylic acid.
What is the SMILES notation for (2R)-4-[[2-[4-bromo-1-(cyclopropylmethyl)benzotriazol-5-yl]oxy-5-fluoro-3-pyridinyl]methyl]-2-tert-butyl-2-methylpiperazine-1-carboxylic acid?
The canonical SMILES for (2R)-4-[[2-[4-bromo-1-(cyclopropylmethyl)benzotriazol-5-yl]oxy-5-fluoro-3-pyridinyl]methyl]-2-tert-butyl-2-methylpiperazine-1-carboxylic acid is CC(C)(C)[C@]1(C)CN(Cc2cc(F)cnc2Oc2ccc3c(nnn3CC3CC3)c2Br)CCN1C(=O)O.
What is the InChIKey of (2R)-4-[[2-[4-bromo-1-(cyclopropylmethyl)benzotriazol-5-yl]oxy-5-fluoro-3-pyridinyl]methyl]-2-tert-butyl-2-methylpiperazine-1-carboxylic acid?
The InChIKey is UAUAEYFWMOYMIW-SANMLTNESA-N. The full InChI is InChI=1S/C26H32BrFN6O3/c1-25(2,3)26(4)15-32(9-10-33(26)24(35)36)14-17-11-18(28)12-29-23(17)37-20-8-7-19-22(21(20)27)30-31-34(19)13-16-5-6-16/h7-8,11-12,16H,5-6,9-10,13-15H2,1-4H3,(H,35,36)/t26-/m0/s1.
What are the key properties of (2R)-4-[[2-[4-bromo-1-(cyclopropylmethyl)benzotriazol-5-yl]oxy-5-fluoro-3-pyridinyl]methyl]-2-tert-butyl-2-methylpiperazine-1-carboxylic acid?
(2R)-4-[[2-[4-bromo-1-(cyclopropylmethyl)benzotriazol-5-yl]oxy-5-fluoro-3-pyridinyl]methyl]-2-tert-butyl-2-methylpiperazine-1-carboxylic acid has a molecular weight of 575.48 g/mol, XLogP of 5.53, 6 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-4-[[2-[4-bromo-1-(cyclopropylmethyl)benzotriazol-5-yl]oxy-5-fluoro-3-pyridinyl]methyl]-2-tert-butyl-2-methylpiperazine-1-carboxylic acid is sourced from PubChem (CID 67955411), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).